Clinical Trial Update: Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma

View source ↗

Summary

A completed clinical trial evaluating the relationship between tumor absorbed dose and treatment response in meningioma patients treated with Lutetium-177 DOTAT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Meningioma of Brain | Status: COMPLETED